百时美施贵宝Bristol Myers Squibb Co. (BMY) 2010年年度报告「NYSE」.pdf

1、Bristol-Myers Squibb345 Park Avenue New York,NY 10154-0037 212-546-4000 Get the free mobile app at http:/gettag.mobi2010 ANNUAL REPORTOUR BIOPHARMA TRANSFORMATIONSignificant Changes.Significant Results.We stand today as a global company deeply committed to a single Mission:to discover,develop and de

2、liver innovative medicines that help patients prevail over serious diseases.Chief Executive Officer Lamberto Andreotti(front center)with members of the Senior Management Team.See page 103.FRONT COVERJennifer Lowinger is a research scientist in Applied Genomics at Bristol-Myers Squibb.She is part of

3、an R&D team exploring the use of chemical genetics to identify new disease targets,one of the first steps in drug discovery and development.BACK COVERJanice Henn,pictured with her Yorkshire terrier,Killer,was diagnosed with rheumatoid arthritis when she was 35 years old.That was 28 years ago.“No mat

4、ter what I did for 25 years I didnt find anything to stop it,”she says.Arthritis took its toll on everything she enjoyed doing:gardening,walking the dog,family vacations and playing with her grandchildren.“When I walked,it felt like my bones were frozen,like they were going to break every step I too

5、k,”says Janice.In 2008,at the recommen-dation of her doctor,Janice entered a clinical trial for Orencia(abatacept)subcutaneous formulation.Since entering the trial,her condition has improved.“I feel like Im a participant in life again,rather than just an observer,”she says.“Im so grateful.”In 2004,j

6、ust two weeks before her wedding,Sharon Belvin learned that what she thought was a bad case of bronchitis was in fact melanoma.Despite chemo-therapy,the tumors spread to her lungs,lymph nodes and brain.“I was only 22,”she says,“and it seemed like my life was over.”But Sharon didnt give up.She enroll